The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Lilly; Lilly; Lilly; Lilly
Stock and Other Ownership Interests - Lilly; Lilly; Lilly; Lilly
Ramucirumab (RAM) or merestinib (MER) or placebo (PL) plus gemcitabine (GEM) and cisplatin (CIS) as first-line treatment for advanced or metastatic biliary tract cancer (BTC): A randomized, double-blind, phase II study.
 
Juan W. Valle
Honoraria - Ipsen; Ipsen; Ipsen; Ipsen
Consulting or Advisory Role - Agios; Agios; Agios; Agios; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Debiopharm Group; Debiopharm Group; Debiopharm Group; Debiopharm Group; Delcath Systems; Delcath Systems; Delcath Systems; Delcath Systems; Genoscience Pharma; Genoscience Pharma; Genoscience Pharma; Genoscience Pharma; Incyte; Incyte; Incyte; Incyte; Ipsen; Ipsen; Ipsen; Ipsen; Keocyt; Keocyt; Keocyt; Keocyt; Merck; Merck; Merck; Merck; Mundipharma; Mundipharma; Mundipharma; Mundipharma; Novartis; Novartis; Novartis; Novartis; Nucana; Nucana; Nucana; Nucana; PCI Biotech; PCI Biotech; PCI Biotech; PCI Biotech; Pfizer; Pfizer; Pfizer; Pfizer; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; QED Therapeutics; QED Therapeutics; QED Therapeutics; QED Therapeutics; SERVIER; SERVIER; SERVIER; SERVIER; Wren Laboratories; Wren Laboratories; Wren Laboratories; Wren Laboratories
Speakers' Bureau - Imaging Equipment Limited; Imaging Equipment Limited; Imaging Equipment Limited; Imaging Equipment Limited; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Nucana; Nucana; Nucana; Nucana
Research Funding - Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene; Nucana; Nucana; Nucana; Nucana; Pfizer; Pfizer; Pfizer; Pfizer
 
Li-Yuan Bai
Honoraria - Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Pfizer; Pfizer; Pfizer; Pfizer; SynCoreBio; SynCoreBio; SynCoreBio; SynCoreBio
 
Rashida Orlova
No Relationships to Disclose
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Lilly; Lilly; Lilly; Lilly; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
Research Funding - amgen (Inst); amgen (Inst); amgen (Inst); amgen (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst)
 
Jorge Adeva Alfonso
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene
Research Funding - Agios; Agios; Agios; Agios; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; Lilly; Lilly; Lilly; Lilly
Travel, Accommodations, Expenses - Acraf; Acraf; Acraf; Acraf; Merck Serono; Merck Serono; Merck Serono; Merck Serono
 
Li-Tzong Chen
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; PharmaEngine; PharmaEngine; PharmaEngine; PharmaEngine; TTY Biopharm; TTY Biopharm; TTY Biopharm; TTY Biopharm
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; PharmaEngine; PharmaEngine; PharmaEngine; PharmaEngine; SynCoreBio; SynCoreBio; SynCoreBio; SynCoreBio; TTY Biopharm; TTY Biopharm; TTY Biopharm; TTY Biopharm
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Polaris (Inst); Polaris (Inst); Polaris (Inst); Polaris (Inst); SynCoreBio (Inst); SynCoreBio (Inst); SynCoreBio (Inst); SynCoreBio (Inst); TTY Biopharm (Inst); TTY Biopharm (Inst); TTY Biopharm (Inst); TTY Biopharm (Inst)
Patents, Royalties, Other Intellectual Property - anti-alpha-enolase (ENO-1) monoclonal antibody to HuniLife Technology, Taiwan; anti-alpha-enolase (ENO-1) monoclonal antibody to HuniLife Technology, Taiwan; anti-alpha-enolase (ENO-1) monoclonal antibody to HuniLife Technology, Taiwan; anti-alpha-enolase (ENO-1) monoclonal antibody to HuniLife Technology, Taiwan
 
Radka Obermannova
Consulting or Advisory Role - Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; SERVIER; SERVIER; SERVIER; SERVIER
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; SERVIER; SERVIER; SERVIER; SERVIER
Research Funding - Merck; Merck; Merck; Merck
 
Thomas Jens Ettrich
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Sanofi; Sanofi; Sanofi; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Sanofi; Sanofi; Sanofi; Sanofi
Research Funding - Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen; Ipsen; Ipsen; Ipsen; Ipsen; Ipsen; Ipsen; Ipsen
 
Jen-Shi Chen
Consulting or Advisory Role - Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Lilly; Lilly; Lilly; Lilly; MedImmune; MedImmune; MedImmune; MedImmune; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Roche; Roche; Roche; Roche; TTY Biopharm; TTY Biopharm; TTY Biopharm; TTY Biopharm
 
Harpreet Singh Wasan
Honoraria - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Celgene; Celgene; Celgene; Celgene; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Servier; Servier; Servier; Servier; Shire; Shire; Shire; Shire; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Consulting or Advisory Role - ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; Incyte; Incyte; Incyte; Incyte; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche Pharma AG; Roche Pharma AG; Roche Pharma AG; Roche Pharma AG; Shire; Shire; Shire; Shire; Sirtex medical; Sirtex medical; Sirtex medical; Sirtex medical
Speakers' Bureau - Celgene; Celgene; Celgene; Celgene; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; SERVIER; SERVIER; SERVIER; SERVIER; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Research Funding - Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst)
 
Crystal S. Denlinger
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; BeiGene; BeiGene; BeiGene; BeiGene; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck
Research Funding - Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lycera (Inst); Lycera (Inst); Lycera (Inst); Lycera (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Zymeworks (Inst); Zymeworks (Inst); Zymeworks (Inst); Zymeworks (Inst)
 
Arndt Vogel
Honoraria - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Delcath Systems; Delcath Systems; Delcath Systems; Delcath Systems; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Baxalta; Baxalta; Baxalta; Baxalta; Bayer; Bayer; Bayer; Bayer; Delcath Systems; Delcath Systems; Delcath Systems; Delcath Systems; Lilly; Lilly; Lilly; Lilly; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche
Research Funding - Novartis; Novartis; Novartis; Novartis
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen; Roche; Roche; Roche; Roche
 
Aiwu Ruth He
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; Genentech; Genentech; Merck; Merck; Merck; Merck
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Exelis; Exelis; Exelis; Exelis
Research Funding - Genentech; Genentech; Genentech; Genentech; Merck; Merck; Merck; Merck
 
Nathalie Bousmans
Employment - Lilly; Lilly; Lilly; Lilly
 
Allicia C Girvan
Employment - Lilly; Lilly; Lilly; Lilly
Stock and Other Ownership Interests - Lilly; Lilly; Lilly; Lilly
 
Wei Zhang
Employment - Lilly; Lilly; Lilly; Lilly
 
Richard A. Walgren
Employment - Lilly; Lilly; Lilly; Lilly
Stock and Other Ownership Interests - Lilly; Lilly; Lilly; Lilly
Patents, Royalties, Other Intellectual Property - Patent applicant/holder, without royalties, for therapeutic applications related to ramucirumab and merestinib. (Inst); Patent applicant/holder, without royalties, for therapeutic applications related to ramucirumab and merestinib. (Inst); Patent applicant/holder, without royalties, for therapeutic applications related to ramucirumab and merestinib. (Inst); Patent applicant/holder, without royalties, for therapeutic applications related to ramucirumab and merestinib. (Inst)
 
Roberto Carlesi
No Relationships to Disclose
 
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Halozyme; Halozyme; Halozyme; Halozyme; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Zymeworks; Zymeworks; Zymeworks; Zymeworks
Research Funding - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Lilly; Lilly; Lilly; Lilly